Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe licensed weight loss injections available in the UK — tirzepatide (Mounjaro) and semaglutide (Wegovy) — typically produce noticeable changes in appetite within the first one to four weeks, with measurable weight loss building over months rather than days. Trial data show average reductions of around 15–22% of body weight over 68–72 weeks, depending on the medicine and dose. Both are prescription-only medicines; a prescriber assesses your suitability before treatment begins. Expectations about speed matter here, because the injections that work most reliably are not always the ones that feel fastest in week one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Both medicines begin acting on hunger-regulating receptors from the first injection. Most people report a reduced appetite and earlier fullness within the first two to four weeks, even at the lowest starting doses. What varies is how pronounced that effect feels, and how quickly the body weight shifts on the scale.
Tirzepatide activates two receptors (GIP and GLP-1) while semaglutide targets GLP-1 alone. In the SURMOUNT-1 trial, people taking tirzepatide 15 mg lost an average of around 20–21% of their body weight over 72 weeks. In the STEP 1 trial of semaglutide 2.4 mg, the average was roughly 15% over 68 weeks. The SURMOUNT-1 results, published in the New England Journal of Medicine, involved 2,539 adults with obesity, and by week 20, meaningful separation from placebo was already visible on the weight-loss curves.
The head-to-head comparison came with SURMOUNT-5 (NEJM, 2025), which found tirzepatide produced greater average loss than semaglutide 2.4 mg over 72 weeks. That said, semaglutide is well-established and works well for many people. Which one suits you depends on your health history, not just which number looks larger. If you want to read more about how the two medicines compare week by week, our page on which weight loss injection works the fastest goes deeper on the evidence.
A common misconception is that starting at 2.5 mg (tirzepatide) or 0.25 mg (semaglutide) means you are not getting any real benefit yet. That is not quite right. The titration schedule exists primarily to let your digestive system adapt, reducing the nausea, vomiting and reflux that can occur when the full dose hits without that gradual build. Skipping steps does not accelerate fat loss, it mostly accelerates side effects.
The prescriber controls dose increases, typically at four-week intervals, based on how you are tolerating the current dose. People who push through rapid titration unsupervised often end up pausing treatment because of GI symptoms, which costs more time than the schedule would have. The NHS tirzepatide information page covers common side effects in plain terms and is worth reading before you start.
In practice, many people notice their clothes fitting differently within six to eight weeks, even at earlier doses. That is a meaningful sign the medicine is working, even if the scale has not moved as dramatically as expected. Weight loss is rarely linear, there are weeks of plateau followed by a shift. A prescriber or aftercare team can help you read that pattern rather than second-guessing it alone. If your injections do not seem to be working as expected, the page on weight loss injections not working covers the most common reasons and what can be done.
Beyond the medicine itself, several factors influence how fast the results come through. Protein intake matters, people losing weight quickly can lose muscle alongside fat, and eating enough protein (alongside some resistance activity) helps preserve lean mass, which keeps metabolism higher. Hydration is important too, partly because the medicines can cause fluid loss through reduced appetite and GI effects.
Consistency is the single biggest practical factor. These are weekly injections, and missing a dose breaks the steady plasma level the medicine relies on. Rotating injection sites (abdomen, thigh, upper arm) on a regular basis prevents local skin reactions that can affect absorption. Our page on how weight loss injections work has more detail on the practical side.
It is also worth knowing that individual response genuinely varies. Two people on the same dose can see quite different results at the same time point, this is not a sign that one of them is doing something wrong. Genetics, gut microbiome composition, baseline insulin sensitivity and medication interactions all play a role. If progress stalls, the right move is a clinical conversation, not a switch to whatever supplement is trending online. For context on treatment costs and what a legitimate private prescription includes, our weight loss treatments page sets out what to expect.
Searches for the fastest-working options sometimes surface products that sit well outside the licensed medicines available in the UK, unlicensed compounded peptides, injectable mixtures sold without a prescription, and counterfeit versions of Mounjaro or Wegovy pens. The MHRA has issued repeated warnings about fake weight-loss pens, some of which have been found to contain insulin rather than the labelled medicine, with serious consequences for people who used them.
Speed-as-advertising is one of the clearest red flags in this space. A seller promoting an injectable weight-loss product with no mention of clinical assessment, no GPhC-registered pharmacy behind it, and a price far below the realistic market range is not offering a faster route, it is offering a less safe one. You can check whether any online pharmacy is genuinely registered at the GPhC pharmacy register. Suspected sellers of unlicensed or fake products can be reported via the MHRA's Yellow Card scheme.
Licensed tirzepatide and semaglutide are the fastest weight loss injections with a proven evidence base in the UK, and the gap in results between them and unverified alternatives is not close. If you are weighing up your options and want to understand what is the fastest weight loss injection from a clinical standpoint, that page sets out the evidence behind each choice. For a broader look at what is available and clinically supported, the weight loss injections overview is a useful starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.